Small business set-aside programs are meant to give the little guys a fighting chance in the competitive world of government contracting. But for one Virginia company, bending the rules to snag those contracts came with a hefty price tag.
In a move that feels long overdue for millions of Americans, the Consumer Financial Protection Bureau (CFPB) has delivered a game-changing ruling. Medical debt is officially out of credit reports. Yes, those maddening medical bills you didn’t realize you owed—or thought were covered by insurance—can no longer tank your credit score.
In a historic move, the Federal Trade Commission (FTC) has hit three major oil companies—XCL Resources Holdings, LLC (XCL), Verdun Oil Company II LLC (Verdun), and EP Energy LLC (EP)—with a $5.6 million fine. The fine settles allegations that the companies violated antitrust laws through illegal coordination before a merger, a practice known as “gun jumping.” This marks the largest penalty ever imposed for such a violation in U.S. history.
Let’s face it—data privacy isn’t the most glamorous New Year’s resolution. It’s not going to help you fit into that old pair of jeans or finally get through “War and Peace.” But as the UK’s Information Commissioner’s Office (ICO) reminds us, tightening up your data security is the kind of life upgrade that could save you from stress, financial loss, and a few sleepless nights.
Imagine buying your dream home—a manufactured haven meant to provide stability and shelter for your family. Now imagine that dream slipping away, month by month, as you struggle to make payments, juggling necessities like food, healthcare, and basic living expenses. For many families, this isn’t just a nightmare; it’s their reality, and according to the Consumer Financial Protection Bureau (CFPB), Vanderbilt Mortgage & Finance is to blame.
For many Chief Information Security Officers (CISOs), the role was once about fortifying systems, dodging ransomware, and endlessly justifying cybersecurity budgets. But a new survey from BlackFog shows that the job now comes with a far weightier burden: the risk of personal liability.
When it comes to scientific research, the stakes are high. For Athira Pharma Inc., a biotech firm headquartered in Bothwell, Washington, the fallout from allegations of research misconduct has culminated in a $4 million settlement with the federal government. At the heart of the matter is a breach of trust—both with federal funding agencies and the public—that underscores just how vital transparency is in the pursuit of scientific progress.